A blog about chemistry, drug development, science, and technology
Another merger from earlier this week (article is from Oct 13).
RedOrbit - Health - Pennsylvania Company Buys RxKinetix
Endo Pharmaceuticals is going to buy RxKinetix Inc. based on Boulder, CO for $95 million. RxKinetix Inc. is developing a drug called RK-0202 to treat mouth sores associated with chemotherapy. Not much else to report on this but it is part of a larger continuing merger activity in the pharmaceutical industry
Technorati Tags: Endo Pharmaceuticals, pharma M&A, pharmaceutical deals, RxKinetix Inc
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 0.873 seconds